BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7189952)

  • 1. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 2. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
    [No Abstract]   [Full Text] [Related]  

  • 4. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
    Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
    Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
    J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
    Das J; Vu T; Harris DN; Ogletree ML
    J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
    Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
    J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane, and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets.
    Wilson NH; Peesapati V; Jones RL; Hamilton K
    J Med Chem; 1982 May; 25(5):495-500. PubMed ID: 7086834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on prostaglandins. III. Synthesis of bicyclo[4.3.0]nonane derivatives.
    Inukai N; Iwamoto H; Tamura T; Yanagisawa I; Ishii Y; Takagi T; Tomioka K; Murakami M
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1414-7. PubMed ID: 1021296
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
    Fitzpatrick T; Harris R; Ramwell P; Kot P
    Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
    Spławiński J; Wojtaszek B; Marcinkiewicz E
    Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 19. Membrane protein mediation of thromboxane A2-induced platelet aggregation.
    Kao KJ; Hagen PO; Pizzo SV
    Biochem Biophys Res Commun; 1980 Nov; 97(1):87-93. PubMed ID: 6779820
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.